Relationship of Treatment-Resistant Head Lice to the Safety and Efficacy of Pediculicides

Mayo Clinic Proceedings

Volumn 79, Issue 5, 2004, Pages 661-666

  Burkhart, Craig G ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANISE OIL; COCONUT OIL; COTRIMOXAZOLE; IVERMECTIN; LINDANE; MALATHION; NON PRESCRIPTION DRUG; PERMETHRIN; PYRETHRIN; YLANG YLANG OIL;

ADVERSE DRUG REACTION; CONJUNCTIVITIS; DIAGNOSTIC ERROR; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EDEMA; ERYTHEMA; FLAMMABILITY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HIGH RISK POPULATION; HUMAN; HYPESTHESIA; NEUROTOXICITY; PARESTHESIA; PEDICULOSIS CAPITIS; PEDICULUS; PESTICIDE RESISTANCE; PRESCRIPTION; PRURITUS; RASH; REVIEW; SCALP; SCALP IRRITATION; SEIZURE; SELF MEDICATION; SKIN IRRITATION; TREATMENT FAILURE;

EID: 2342505826     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.5.661     Document Type: Review

References (34)

1. Frankowski BL, Weiner LB, Committee on School Health, Committee on Infectious Diseases, American Academy of Pediatrics. Head lice. Pediatrics. 2002;110:638-643.
2. Meinking TL, Burkhart CN, Burkhart CO. Infestations. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Vol 1. London, England: Mosby; 2003:1321-1332.
3. Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138:220-224.
4. Hansen RC, Working Group on the Treatment of Resistant Pediculosis. Guidelines for the treatment of resistant pediculosis. Contemp Pediatr. 2000;17(suppl):1-10.
5. Jones KN, English JC III. Review of common therapeutic options in the United States for the treatment of pediculosis capitis. Clin Infect Dis. 2003;36:1355-1361.
6. Burkhart CN, Burkhart CG. Topical pyrethroids: assessment of function and efficacy in head lice. Int Pediatr. 2002;17:209-212.
7. Narahashi T, Ginsburg KS, Nagata K, Song JH, Tatebayashi H. Ion channels as targets for insecticides. Neurotoxicology. 1998;19:581-590.
8. Burkhart CG, Burkhart CN. Clinical evidence of lice resistance to over-the-counter products. J Cutan Med Surg. 2000;4:199-201.
9. Meinking TL, Entzel P, Villar ME, Vicaria M, Lemard GA, Porcelain SL. Comparative efficacy of treatments for pediculosis capitis infestations: update 2000. Arch Dermatol. 2001;137:287-292.
10. Burkhart CN, Burkhart CG. Recommendation to standardize pediculicidal and ovicidal testing for head lice (Anoplura: Pediculidae). J Med Entomol. 2001;38:127-129.
11. Burgess IF, Brown CM, Peock S, Kaufman J. Head lice resistant to pyrethroid insecticides in Britain [letter]. BMJ. 1995;311:752.
12. Dodd CS. Interventions for treating head lice. Cochrane Database Syst Rev. 2001;CD001165.
13. O'Malley M. Clinical evaluation of pesticide exposure and poisonings. Lancet. 1997;349:1161-1166.
14. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med. 1999;153:969-973.
15. Andrews EB, Joseph MC, Magenheim MJ, Tilson HH, Doi PA, Schultz MW. Postmarketing surveillance study of permethrin creme rinse. Am J Public Health. 1992;82:857-861.
16. Code of Federal Regulations. Title 21, Vol 4, Parts 200 to 299. Revised April 1, 1997. Washington, DC: US Government Printing Office. 21CFR201.57;22-23.
17. Center for Drug Evaluation and Research Web site. Lindane shampoo and lindane lotion. Available at: www.fda.gov/cder/drug/infopage/lindane/default.htm. Accessibility verified March 16, 2004.
18. California Department of Health Services. State health director offers tips for protecting children from head lice. October 10, 2000. News Release No. 54-00.
19. Yoon KS, Gao JR, Lee SH, Clark JM, Brown L, Taplin D. Permethrin-resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol. 2003;139:994-1000.
20. Blasiak I, Jaloszynski P, Trzeciak A, Szyfter K. In vitro studies on the genotoxicity of the organophosphorus insecticide malathion and its two analogues. Mutat Res. 1999;445:275-283.
21. Dennis GA, Lee PN. A phase I volunteer study to establish the degree of absorption and effect on cholinesterase activity of four head lice preparations containing malathion. Clin Drug Invest. 1999;18:105-115.
22. Youssef MY, Sadaka HA, Eissa MM, el-Ariny AF. Topical application of ivermectin for human ectoparasites. Am J Trop Med Hyg. 1995;53:652-653.
23. Glaziou P, Nyguyen LN, Moulia-Pelat JP, Cartel JL, Martin PM. Efficacy of ivermectin for the treatment of head lice (Pediculosis capitis). Trop Med Parasitol. 1994;45:253-254.
24. Burkhart CN. Ivermectin: an assessment of its pharmacology, microbiology and safety. Vet Hum Toxicol. 2000;42:30-35.
25. Burkhart CN. Nit Sheath and Bacterial Symbiotes of the Human Head Louse (Pediculus humanus capitis) [master's thesis]. Toledo: Medical College of Ohio; 2003.
26. Sim S, Lee IY, Lee KJ, et al. A survey on head lice infestation in Korea (2001) and the therapeutic efficacy of oral trimethoprim/ sulfamethoxazole adding to lindane shampoo. Korean J Parasitol. 2003;41:57-61.
27. Hipolito RB, Mallorca FG, Zuniga-Macaraig ZO, Apolinario PC, Wheeler-Sherman J. Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatrics. 2001;107:E30.
28. Morsy TA, Ramadan NI, Mahmoud MS, Lashen AH. On the efficacy of Co-trimoxazole as an oral treatment for pediculosis capitis infestation. J Egypt Soc Parasitol. 1996;26:73-77.
29. Mumcuoglu KY, Miller J, Zamir C, Zentner G, Helbin V, Ingber A. The in vivo pediculicidal efficacy of a natural remedy. Isr Med Assoc J. 2002;4:790-793.
30. Nakamura T, Okuyama E, Yamazaki M. Neurotropic components from star anise (Illicium verum Hook. fil.) [published correction appears in Chem Pharm Bull (Tokyo). 1996;44:2344). Chem Pharm Bull (Tokyo). 1996-44:1908-1914.
31. Nakamura T, Okuyama E, Yamazaki M. Neurotropic components from star anise (Illicium verum Hook. fil.) [published correction appears in Chem Pharm Bull (Tokyo). 1996;44:2344). Chem Pharm Bull (Tokyo). 1996-44:1908-1914.
32. Garzo Fernandez C, Gomez Pintado P, Barrasa Blanco A, Martinez Arrieta R, Ramirez Fernandez R, Ramon Rosa F, Grupo de Trabajo del Anis Estrellado. Cases of neurological symptoms associated with star anise consumption used as a carminative [in Spanish]. An Esp Pediatr. 2002;57:290-294.
33. Kakemoto E, Okuyama E, Nagata K, Ozoe Y. Interaction of anisatin with rat brain gamma-aminobutyric acidA receptors: allosteric modulation by competitive antagonists. Biochem Pharmacol. 1999;58:617-621.
34. Meinking TL, Clineschmidt CM, Chen C, et al. An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice. J Pediatr. 2002;141:665-670.